ArticleOncotarget2015

Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2--implications for a combinatorial treatment.

Charlotte Fristedt Duvefelt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.